PEDF in Angiogenic Eye Diseases
Journal:
Current Molecular Medicine
Volume:
10
Page:
267-278
Author(s):
J. Tombran-Tink
Anti-Vasopermeability Effects of PEDF in Retinal-Renal Disorders
Journal:
Current Molecular Medicine
Volume:
10
Page:
279-283
Author(s):
S. Ueda, S.-I. Yamagishi and S. Okuda
The Neuroprotective Role of PEDF: Implication for the Therapy of Neurological Disorders
Journal:
Current Molecular Medicine
Volume:
10
Page:
259-266
Author(s):
T. Yabe, T. Sanagi and H. Yamada
Cell Cycle as a Target of Antineoplastic Drugs
Journal:
Current Pharmaceutical Design
Volume:
16
Page:
1417-1426
Author(s):
Maria De Falco and Antonio De Luca
Nutlins and Ionizing Radiation in Cancer Therapy
Journal:
Current Pharmaceutical Design
Volume:
16
Page:
1427-1442
Author(s):
Gianna Impicciatore, Silvia Sancilio, Sebastiano Miscia and Roberta Di Pietro
Bone Morphogenetic Proteins and its Receptors; Therapeutic Targets in Cancer Progression and Bone Metastasis?
Journal:
Current Pharmaceutical Design
Volume:
16
Page:
1291-1300
Author(s):
Jeroen T. Buijs, Maj Petersen, Geertje van der Horst and Gabri van der Pluijm
CDK Inhibitors: From the Bench to Clinical Trials
Journal:
Current Drug Targets
Volume:
11
Page:
279-290
Author(s):
Flavio Rizzolio, Tiziano Tuccinardi, Isabella Caligiuri, Chiara Lucchetti and Antonio Giordano
Cyclin-Dependent Kinase Inhibitors as Anticancer Drugs
Journal:
Current Drug Targets
Volume:
11
Page:
291-302
Author(s):
Vladimir Krystof and Stjepan Uldrijan
Telomere Maintenance as Therapeutic Target in Embryonal Tumours
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
10
Page:
196-212
Author(s):
T. Shalaby, E. Hiyama and M.A. Grotzer
The Vitamin D/CYP24A1 Story in Cancer
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
10
Page:
213-224
Author(s):
Amanda N. King, David G. Beer, Paul J. Christensen, Robert U. Simpson and Nithya Ramnath